Clinical Trial

Optimised Treatment for Hypertension Trial

Study acronym: OPTIMISE-BP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized trial compares two prescribing strategies to treat high blood pressure. One approach involves remote treatment informed by randomized trial evidence without regular monitoring of blood pressure ("fire and forget"), whilst the other involves usual care treatment with access to frequent blood pressure monitoring. The study will enrol participants with uncontrolled high blood pressure and randomize participants 1:1 to a "fire and forget" treatment group or a "more blood pressure monitoring" group for a total of 12 weeks. "Fire and forget" involves choosing the most appropriate treatment based on the highest quality evidence (randomized trial data), after which participants will stop measuring blood pressures until the end of study. The "more blood pressure monitoring" group will involve treatment as usual but with the access to frequent and high quality blood pressure monitoring. The goal of this research is to: 1. determine which prescribing approach is more effective at lowering blood pressure after 12 weeks (end of study) 2. assess the safety, feasibility and acceptability of the two treatment approaches.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-13.
Trial Details
NCT Number NCT06935760
Lead Sponsor The George Institute
Conditions Hypertension
Enrollment 120 participants
Start Date 2025-08-28
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-21